Mortality of Chinese patients with polymyositis and dermatomyositis.
Xinlei YangYanjie HaoXiaohui ZhangYan GengLanlan JiGuangtao LiZhuoli ZhangPublished in: Clinical rheumatology (2020)
Mortality of PM/DM patients in China is substantial, especially in females, and those with ILD, malignancy or infection. Infection was the leading cause of death. Patients with older age at onset, infection, ILD, and malignancy need to be paid more attention. Key Points • This is the first comprehensive report about the mortality situation with a large population in PM/DM patients in China including SMR, YLL, and cause of death, Kaplan-Meier survival analysis and Cox regression analysis for mortality risk factors. • The specific SMRs for PM/DM patients with malignancy and interstitial lung disease were also reported in this study. To our knowledge, only two studies worldwide reported SMRs in PM/DM patients and no figure about YLL was reported so far. • Overall, the mortality figures in this study were higher than those from the western countries, and the leading cause of death was different from the western countries.
Keyphrases
- interstitial lung disease
- risk factors
- systemic sclerosis
- ejection fraction
- newly diagnosed
- air pollution
- cardiovascular events
- particulate matter
- type diabetes
- prognostic factors
- healthcare
- idiopathic pulmonary fibrosis
- adipose tissue
- polycyclic aromatic hydrocarbons
- patient reported outcomes
- physical activity
- cardiovascular disease
- coronary artery disease
- glycemic control
- systemic lupus erythematosus
- metabolic syndrome
- patient reported
- peritoneal dialysis
- middle aged